[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C@@H:8]2[O:14][CH2:13][CH2:12][N:11](C(OC(C)(C)C)=O)[CH2:10][C@H:9]2[CH2:22][NH:23][C:24](=[O:30])[CH2:25][O:26][CH:27]([CH3:29])[CH3:28])=[CH:4][C:3]=1[F:31].C(OCC)(=O)C.Cl>>[ClH:1].[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C@@H:8]2[O:14][CH2:13][CH2:12][NH:11][CH2:10][C@H:9]2[CH2:22][NH:23][C:24](=[O:30])[CH2:25][O:26][CH:27]([CH3:28])[CH3:29])=[CH:4][C:3]=1[F:31]To tert-butyl (6R,7R)-7-(4-chloro-3-fluorophenyl)-6-({[(1-methylethoxy)acetyl]amino}methyl)-1,4-oxazepane-4-carboxylate (384 mg) was added 4.0 M hydrogen chloride-ethyl acetate solution (6.28 ml), and the mixture was stirred at room temperature for 1 hr. The residue obtained by concentration under reduced pressure was crystallized from ethanol-hexane solvent to give the title compound (153.4 mg).